|
MLXIP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.11197767344629E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.92629995182858E-09 |
| Normal-vs-Stage2 |
1.172850E-04 |
| Normal-vs-Stage3 |
8.60422844084496E-14 |
| Normal-vs-Stage4 |
1.7731038859381E-11 |
| Stage1-vs-Stage2 |
3.686800E-01 |
| Stage1-vs-Stage3 |
1.198200E-01 |
| Stage1-vs-Stage4 |
7.192400E-02 |
| Stage2-vs-Stage3 |
7.504400E-02 |
| Stage2-vs-Stage4 |
4.884300E-02 |
| Stage3-vs-Stage4 |
6.939000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.05059969005106E-10 |
| Normal-vs-AfricanAmerican |
1.71805999999997E-05 |
| Normal-vs-Asian |
3.12400000312962E-08 |
| Caucasian-vs-AfricanAmerican |
8.674200E-01 |
| Caucasian-vs-Asian |
9.902000E-01 |
| AfricanAmerican-vs-Asian |
8.947200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.6942005837991E-11 |
| Normal-vs-Female |
7.7717055013693E-11 |
| Male-vs-Female |
7.641000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.50940371312913E-11 |
| Normal-vs-Age(41-60Yrs) |
1.86719995021178E-09 |
| Normal-vs-Age(61-80Yrs) |
7.37410132956029E-12 |
| Normal-vs-Age(81-100Yrs) |
1.004310E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.787600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.237000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.204400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.408400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.124000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.468600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.25510000000573E-05 |
| Classical-VS-Follicular |
7.325000E-01 |
| Classical-VS-Other |
3.792400E-02 |
| Classical-VS-Normal |
1.91235915991683E-12 |
| Tall-VS-Follicular |
8.619700E-03 |
| Tall-VS-Other |
3.174600E-01 |
| Tall-VS-Normal |
6.0063065632221E-14 |
| Follicular-VS-Other |
5.201400E-03 |
| Follicular-VS-Normal |
3.72590000000672E-05 |
| Other-VS-Normal |
8.67399999604501E-08 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.40659706104884E-11 |
| Normal-vs-N1 |
2.41380004872838E-09 |
| N0-vs-N1 |
5.799000E-01 |
|
|
